Evidence map›Paper›PMID 36472499›Full record

ArticlePlastic and reconstructive surgery2023

Acellular Nipple Scaffold Development, Characterization, and Preliminary Biocompatibility Assessment in a Swine Model.

Ruben V Oganesyan, Alexandre G Lellouch, Aylin Acun, Elise Lupon, Corentin B Taveau, Laura C Burlage, Laurent A Lantieri, Mark A Randolph, Curtis L Cetrulo, Basak E Uygun

Open access · greenAbstract read
In one paragraph

Article in Plastic and reconstructive surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Ruben V OganesyanFrom the Center for Engineering in Medicine and Surgery, Department of Surgery.
Alexandre G LellouchShriners Children's Boston.
Aylin AcunFrom the Center for Engineering in Medicine and Surgery, Department of Surgery.
Elise LuponDivision of Plastic and Reconstructive Surgery.
Corentin B TaveauDepartment of Plastic Surgery, European George Pompidou Hospital, University of Paris.
Laura C BurlageDivision of Plastic and Reconstructive Surgery.
Laurent A LantieriDepartment of Plastic Surgery, European George Pompidou Hospital, University of Paris.
Mark A RandolphVascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School.
Curtis L CetruloDivision of Plastic and Reconstructive Surgery.
Basak E UygunFrom the Center for Engineering in Medicine and Surgery, Department of Surgery.
Center for Excellence in Education · USHarvard University · USHôpital Européen Georges-Pompidou · FRMassachusetts General Hospital · USUniversity of Amsterdam · NL

Funding

Development of engineered fasciocutaneous skin flapsR01AR082825 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Basak Elif Uygun · 2023 to 2026
$1.4M
NIAMS NIH HHS R01 AR082825
6 · The paper itself

Abstract

backgroundThe standard in nipple reconstruction remains the autologous skin flap. Unfortunately, the results are not satisfying, with up to 75% loss of nipple projection over time. Existing studies investigated the use of primates as a source of implants. The authors hypothesized that the porcine nipple can serve as a perfect shape-supporting implant because of functional similarities to the human nipple. A decellularization protocol was developed to obtain an acellular nipple scaffold (ANS) for nipple reconstruction.

methodsTissue samples were collected from eight disease-free female Yorkshire pigs (60 to 70 kg) and then decellularized. The decellularization efficiency and extracellular matrix characterization was performed histologically and quantitatively (DNA, total collagen, elastin, and glycosaminoglycan content). In vitro and in vivo biocompatibility was determined by human dermal fibroblast culture and subcutaneous implantation of six ANSs in a single Yorkshire pig (60 to 70 kg), respectively. Inflammation and adverse events were monitored daily based on local clinical signs.

resultsThe authors showed that all cellular structures and 96% of DNA [321.7 ± 57.6 ng DNA/mg wet tissue versus 11.7 ± 10.9 ng DNA/mg wet tissue, in native and ANS, respectively ( P < 0.001)] can be successfully removed. However, this was associated with a decrease in collagen [89.0 ± 11.4 and 58.8 ± 9.6 μg collagen/mg ( P < 0.001)] and elastin [14.2 ± 1.6 and 7.9 ± 2.4 μg elastin/mg ( P < 0.05)] and an increase in glycosaminoglycan content [5.0 ± 0.7 and 6.0 ± 0.8 ng/mg ( P < 0.05)]. ANS can support continuous cell growth in vitro and during preliminary biocompatibility tests in vivo.

conclusionThis is a preliminary report of a novel promising ANS for nipple reconstruction, but more research is needed to validate results. CLINICAL RELEVANCE STATEMENT: Breast cancer is very common among women. Treatment involves mastectomy, but its consequences affect patient mental well-being, and can lead to depression. Nipple-areola complex reconstruction is critical, and existing methods lead to unsatisfactory outcomes.

Indexed as

Breast NeoplasmsMammaplastyAnimalsCollagenDNAElastinFemaleGlycosaminoglycansHumansMastectomyNipplesRetrospective StudiesSwineCollagenDNAElastinGlycosaminoglycans

Identifiers

PMID36472499
PMCPMC10859846
OpenAlexW4310778878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.